Skip to content
10-Q

Quarterly Report

Cellectar Biosciences, Inc. CLRB

0001410578-25-001205

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 46.08M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $13.91M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $23.29M
Current Liabilities Q1 2025 · Mar 31, 2025 $6.02M
Current Liabilities Q1 2025 · Dec 31, 2024 $9.39M
Total Liabilities Q1 2025 · Mar 31, 2025 $6.41M
Total Liabilities Q1 2025 · Dec 31, 2024 $9.8M
Current Assets Q1 2025 · Mar 31, 2025 $14.89M
Current Assets Q1 2025 · Dec 31, 2024 $24.25M
Total Assets Q1 2025 · Mar 31, 2025 $16.04M
Total Assets Q1 2025 · Dec 31, 2024 $25.47M